UA71939U - method for evaluation of effectiveness of anti-hypertensive effect of olmesartan in combination with indapamide in patients with arterial hypertension that flows at background of obesity - Google Patents

method for evaluation of effectiveness of anti-hypertensive effect of olmesartan in combination with indapamide in patients with arterial hypertension that flows at background of obesity

Info

Publication number
UA71939U
UA71939U UAU201202624U UAU201202624U UA71939U UA 71939 U UA71939 U UA 71939U UA U201202624 U UAU201202624 U UA U201202624U UA U201202624 U UAU201202624 U UA U201202624U UA 71939 U UA71939 U UA 71939U
Authority
UA
Ukraine
Prior art keywords
indapamide
olmesartan
combination
obesity
arterial hypertension
Prior art date
Application number
UAU201202624U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Александр Николаевич Биловол
Вера Владиславовна Школьник
Original Assignee
Харьковский Национальный Медицинский Университет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харьковский Национальный Медицинский Университет filed Critical Харьковский Национальный Медицинский Университет
Priority to UAU201202624U priority Critical patent/UA71939U/en
Publication of UA71939U publication Critical patent/UA71939U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for evaluation of effectiveness of anti-hypertensive effect of olmesartan in combination with indapamide in patients with arterial hypertension includes determination in blood plasma of markers of correlation with the level of arterial tension, at that when arterial hypertension flows at background of obesity one determines in blood plasma concentration of grelin and at its increase to 25.6±6.5 pg/ml and higher in course of treatment with combination of olmesartan with indapamide this is considered as manifestation of anti-hypertensive effect.
UAU201202624U 2012-03-05 2012-03-05 method for evaluation of effectiveness of anti-hypertensive effect of olmesartan in combination with indapamide in patients with arterial hypertension that flows at background of obesity UA71939U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201202624U UA71939U (en) 2012-03-05 2012-03-05 method for evaluation of effectiveness of anti-hypertensive effect of olmesartan in combination with indapamide in patients with arterial hypertension that flows at background of obesity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201202624U UA71939U (en) 2012-03-05 2012-03-05 method for evaluation of effectiveness of anti-hypertensive effect of olmesartan in combination with indapamide in patients with arterial hypertension that flows at background of obesity

Publications (1)

Publication Number Publication Date
UA71939U true UA71939U (en) 2012-07-25

Family

ID=50849042

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201202624U UA71939U (en) 2012-03-05 2012-03-05 method for evaluation of effectiveness of anti-hypertensive effect of olmesartan in combination with indapamide in patients with arterial hypertension that flows at background of obesity

Country Status (1)

Country Link
UA (1) UA71939U (en)

Similar Documents

Publication Publication Date Title
EA201690456A1 (en) METHODS OF TREATMENT AND PREVENTION OF ENDOTHELIAL DYSFUNCTION WITH THE USE OF BARDOXOLON METHYL OR ITS ANALOGUES
EA201301354A1 (en) SGLT-2 INHIBITORS DESIGNED FOR THE TREATMENT OF METABOLIC DISORDERS IN PATIENTS TREATED BY NEUROLEPTICS
MY174894A (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
BR112012030592A2 (en) use of liquid enteral nutrition, liquid enteral nutrition, method of preventing or treating malnutrition or low nutrition or reducing the risk of malnutrition or low nutrition in patients suffering from dysphagia, and method of preventing or treating dysphagia in mammals at risk of dysphagia
EA201101117A1 (en) DPP-4 INHIBITORS FOR THE TREATMENT OF DIABETES IN CHILDREN
MX2016013635A (en) Methods for increasing red blood cell levels and treating sickle-cell disease.
EA201590849A1 (en) COMPOSITIONS, METHODS AND APPLICATIONS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS BY MEANS OF CONTROL OF THE BLOOD GLUCOSE
BR112015022047A2 (en) Methods To Treat Bladder Cancer
PH12015502275A1 (en) Therapuetic uses of empagliflozin
EA201200793A1 (en) TREATMENT OF GENOTYPED PATIENTS WITH DIABETES DPP-4 INHIBITORS, SUCH AS LINAGLIPTIN
EA201490559A1 (en) COMPOSITION FOR THE TREATMENT OF Fistula
BR112014012607A2 (en) treatment methods using an interferon gamma inhibitor
MX2016002423A (en) Diagnostic methods and compositions for treatment of glioblastoma.
WO2013082440A3 (en) Methods of treating breast cancer with taxane therapy
EA201691032A1 (en) IZHOCHROMEN DERIVATIVES AS PHOSFOINOSYTID-3-KINAZ INHIBITORS
MX2011006725A (en) Combination of aurora kinase inhibitors and anti-cd20 antibodies.
MX2013001906A (en) Methods of reducing blood lactate concentration.
MX2015013939A (en) Therapeutic uses of empagliflozin.
EA201691020A1 (en) METHODS OF TREATMENT AND PREVENTION OF CALLED ALLOGEN ANTIBODIES OF CHRONIC DISEASE "TRANSPLANTAT AGAINST THE OWNER"
EA201591943A1 (en) METAP2 INHIBITORS AND METHODS OF TREATING OBESITY
EA201291329A1 (en) HETEROCYCLIC COMPOUNDS, THEIR RECEIVING AND THEIR THERAPEUTIC APPLICATION
TR201909158T4 (en) siRNA and its use in methods and compositions for the treatment and / or prevention of eye disorders.
BR112012029657A2 (en) dynamic dual circuit in-line heater
NZ713129A (en) Oxprenolol compositions for treating cancer
WO2014049438A3 (en) Method of non-invasive determination of glucose concentration in blood and device for the implementation thereof